TrialDiabetes care2010

Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetes.

Thomas Forst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.